Literature DB >> 1254731

Glucagon response to hypoglycemia in sympathectomized man.

J P Palmer, D P Henry, J W Benson, D G Johnson, J W Ensinck.   

Abstract

Hypoglycemia stimulates immunoreactive glucagon (IRG) secretion and increases the activity of the sympathetic nervous system. To ascertain if the augmented alpha cell activity evoked by glucopenia is mediated by the adrenergic nervous system, the glucagon response to insulin-induced hypoglycemia of five subjects with neurologically complete cervical transections resulting from trauma, thereby disrupting their hypothalamic sympathetic outflow, was compared to six healthy volunteers. In addition to clinical neurological evaluation, completeness of sympathectomy was verified by failure to raise plasma norepinephrine levels during hypoglycemia compared to the two- and threefold increase observed in controls. Total IRG response (IRG area above basal 0-90 min) and peak IRG levels achieved were the same in the quadriplegics and the controls. Although the glucagon rise tended to be slower, and the peak levels attained occurred later in the quadriplegic patients than in the controls, this response was appropriate for their sugar decline, which was slower and reached the nadir later than in the control subjects. These observations that the glucagon release during insulin-induced hypoglycemia is normal in subjects whose hypothalamic sympathetic outflow has been interrupted provide strong evidence that the sympathetic nervous system does not mediate the glucagon response to hypoglycemia.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1254731      PMCID: PMC436678          DOI: 10.1172/JCI108305

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Pancreatic alpha-cell function in trauma.

Authors:  A Lindsey; F Santeusanio; J Braaten; G R Faloona; R H Unger
Journal:  JAMA       Date:  1974-02-18       Impact factor: 56.272

2.  Insulin and glucagon release from monolayer cell cultures of pancreas from newborn rats.

Authors:  E B Marliss; C B Wollheim; B Blondel; L Orci; A E Lambert; W Stauffacher; A A Like; A E Renold
Journal:  Eur J Clin Invest       Date:  1973-01       Impact factor: 4.686

3.  Serum glucagon and insulin levels and their relationship to blood glucose values in patients with acute myocardial infarction and acute coronary insufficiency.

Authors:  J T Willerson; D R Hutcheson; S J Leshin; G R Faloona; R H Unger
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

4.  Stimulation of glucagon secretion by epinephrine in man.

Authors:  J E Gerich; J H Karam; P H Forsham
Journal:  J Clin Endocrinol Metab       Date:  1973-09       Impact factor: 5.958

5.  Arginine-stimulated acute phase of insulin and glucagon secretion. I. in normal man.

Authors:  J P Palmer; R M Walter; J W Ensinck
Journal:  Diabetes       Date:  1975-08       Impact factor: 9.461

6.  Plasma norepinephrine and epinephrine in untreated diabetics, during fasting and after insulin administration.

Authors:  N J Christensen
Journal:  Diabetes       Date:  1974-01       Impact factor: 9.461

7.  Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance.

Authors:  W A Müller; G R Faloona; R H Unger
Journal:  Am J Med       Date:  1973-01       Impact factor: 4.965

8.  Glucagon release induced by pancreatic nerve stimulation in the dog.

Authors:  E B Marliss; L Girardier; J Seydoux; C B Wollheim; Y Kanazawa; L Orci; A E Renold; D Porte
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

9.  Adrenergic receptors and the secretion of glucagon and insulin from the isolated, perfused canine pancreas.

Authors:  J Iversen
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

10.  The effect of adrenergic blockade on the glucagon responses to starvation and hypoglycemia in man.

Authors:  R M Walter; R J Dudl; J P Palmer; J W Ensinck
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

View more
  20 in total

Review 1.  Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.

Authors:  Philip E Cryer
Journal:  Endocrinology       Date:  2011-12-13       Impact factor: 4.736

2.  Role of cortisol in the pathogenesis of deficient counterregulation after antecedent hypoglycemia in normal humans.

Authors:  S N Davis; C Shavers; F Costa; R Mosqueda-Garcia
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 3.  Catecholamines and diabetes mellitus.

Authors:  N J Christensen
Journal:  Diabetologia       Date:  1979-04       Impact factor: 10.122

Review 4.  Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion.

Authors:  B Ahrén; G J Taborsky; D Porte
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

5.  Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas.

Authors:  A Hisatomi; H Maruyama; L Orci; M Vasko; R H Unger
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

6.  Cholinergic stimulation of norepinephrine release in man. Evidence of a sympathetic postganglionic axonal lesion in diabetic adrenergic neuropathy.

Authors:  S A Leveston; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1979-08       Impact factor: 14.808

7.  Improved but not normalized glucose counter-regulation during glucagon infusion in Type 1 (insulin-dependent) diabetes.

Authors:  I Lager; H von Schenck; U Smith
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

8.  Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.

Authors:  R R Dighe; F J Rojas; L Birnbaumer; A J Garber
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

9.  Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.

Authors:  W P Borg; M J During; R S Sherwin; M A Borg; M L Brines; G I Shulman
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

10.  Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.

Authors:  L Saccà; R Sherwin; R Hendler; P Felig
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.